MRI reveals early fat lesion progression in axSpA patients, distinguishing them from non-axSpA chronic back pain cases.

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

A total of 80 pediatric patients with achondroplasia who underwent cervical MRI between 2007 and 2023 were included. Of these, 53 were categorized into the FMSS group based on symptoms such as central ...